Enhancements Provide Safer, Faster, and Easier Treatments
OTTAWA, March 9 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of medical isotopes and radiopharmaceuticals, today announced the launch of an improved administration system for TheraSphere(R), Yttrium-90 Microsphere (Y-90), a targeted internal radiation therapy for patients with inoperable, primary liver cancer. The enhancements to the administration system allow for safer, faster, and more efficient administration of TheraSphere(R), providing better treatment delivery for patients.
The simplified design of the administration system makes TheraSphere(R) even easier to use for physicians. It has fewer parts, is easier to assemble, requires less handling, and reduces set-up time for physicians by approximately 50 per cent.
"As a result of working closely with our physicians, we have taken their feedback and incorporated it into the improved administration system," said MDS Nordion President Steve West. "Through a systematic approach, we've simplified the treatment process by reducing the number of connections required by 40 per cent."
The disposable tubing and tubing connections have been re-designed to minimize barriers and optimize the fluid pathway which is significant for delivery of small particle technology. These improvements optimize dose delivery, providing enhanced safety and ease of use for both medical staff and patients.
"Overall, MDS Nordion incorporated smart enhancements to facilitate the safe and effective delivery of TheraSphere(R) including optimizing access to the dose vial and improving the overall internal flow of the therapy to the affected cells," said Dr. David Wood, Chief of Interventional Radiology, Banner Good Samaritan Medical Center, Phoenix, Arizona. "These upgrades make the administration of TheraSphere(R) to our patients safer and easier."
Dr. May Wahab, Associate Professor of Radiation Oncology, Departmen
'/>"/>
| SOURCE MDS Inc. Copyright©2009 PR Newswire. All rights reserved |